Cobalamin conjugates useful as antitumor agents
US6806363B1 · kind B1 · utility
11Cited by
37References
57Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 16, 2000 |
| Grant date | Oct 19, 2004 |
| Priority date | — |
| Expiry date | Oct 16, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K41/0095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides cobalamin compounds linked to a neutron capture therapy target (e.g. Boron-10 or Gadolinium-157), and optionally linked to a detectable moiety, as well as pharmaceutical compositions comprising the compounds, and methods for using the compounds in medical diagnosis and therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.